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Conclusion: Combined approach of surgica[ re- 
section and the use of the investigationa[ drug 
posaconazote was key to successfutty treat the 
highty [etha[ invasive putmonary mucormycosis n
a heart transptant patient requiring continuous im- 
munosuppression. 
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Vaccine-induced Immunity in Children after 
Orthotopic Liver Transplantation in Switzerland: 
A Twelve Year Review 
A. Diana, K.M. Posfay-Barbe*, D.C. Betti, 
C-A. Siegrist. Children's Hospital oi: Geneva, 
University of Geneva Hospitals, Switzerland 
Introduction E Background: Infections represent 
a significant hreat in sotid-organ recipients. How- 
ever, a certain number of infections can be pre- 
vented by immunizing patients before their trans- 
ptantation. The aim of this study is to determine 
the immunization revers of chitdren undergoing 
transptantation and to assess their capacity to 
maintain protective revers after surgery. 
Methods: Charts of 44 chitdren transptanted with 
cadaveric rivers between 1990 and 2002 at the 
Chitdren's Hospita[ of Geneva were reviewed. Vac- 
cination types and schedutes were compared to 
current recommendations and antibody responses 
to certain antigens were estabtished pre- and post- 
transptantation. 
Results: Onty 43% of patients were up to date for 
diphtheria, tetanus, acettutar pertussis, and potio 
vaccines at the pre-transptant visit, white 44% of 
chitdren order than 12 months had received their 
required meastes-mumps-rubetta shots. Six out of 
44 chitdren had received at [east one dose of hep- 
atitis B vaccine, white onty 2 patients had received 
at [east one dose of hepatitis A vaccine. After 
immunization, and one year after transptantation, 
onty 14/44 patients had detectabte anti-HBs anti- 
bodies and 7/18 had anti-HAV antibodies. Varicetta 
antibodies were undetectabte in 15/19 patients 
immunized prior to transptantation. 
Conclusions: This study hightights the need to en- 
force vaccination before transptantation, fottow- 
up on vaccine-induced immunity, and adapt vac- 
cination schedutes after river transptantation i
chitdren, especiatty for non-tire vaccines which are 
universatty recommended in this poputation. 
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Respiratory Syncytial Virus Infections in Lung 
Transplant Patients: Different Therapeutic 
Approaches Linked to the Degree of 
I mmunosuppression 
I. U~kay*, P. Gasche-Socca[, L. Kaiser, J. Mazza- 
Statder, C. Van Detden. Services o]: Inl:ectious 
Diseases University Hospital Geneva, Switzerland 
Background E Methods: Respiratory syncytial 
virus (RSV) infections in tung transptant pa- 
tients (LTP) have been associated with mortat- 
ity rates between 10% and 70%. Immunogtobu- 
tines (IG), ribavirine and pavitizumab have been 
suggested for both therapeutic and pre-emptive 
therapeutic approaches, however they are [imited 
by toxicity concerns and high costs. In order to 
design a decisiona[ treatment ree we describe 
four cases of proven tower respiratory tract RSV 
infections in tung transptant patients ittustrating 
possibte different ctinica[ approaches. 
Results: Case 1: A 54-year-otd femate LTP was 
hospitatized with cough, bronchitis and rhinorrhea. 
The bronchoatveotar r vage (BAL) grew 105 CFU/m[ 
of S. aureus and S. marcescens suggesting a bacte- 
ria[ pneumonia responding wet[ to cefepime and a 
transient reduction in immunosuppression. Subse- 
quentty a positive PER resutt for RSV was obtained 
from the same BAL. She evotved favourabty with- 
out a therapy against RSV. Case 2: A 28-year-otd 
mate LTP was hospitatized for fever and "common 
cord'. Putmonary functions were ctearty worsened 
compared to two weeks before. The BAL resutts 
suggested a vira[ infection that was treated by a 
reduction in immunosuppression. After one week 
the putmonary functions and ctinica[ symptoms had 
improved. A positive PER for RSV was obtained 
from the origina[ BAL. A specific treatment against 
RSV was not necessary. Case 3: A 48-year-otd fe- 
mate LTP was hospitatized for rhinitis, cough and 
increased sputum production. A tung biopsy re- 
reared an acute A3 rejection. The BAL yietded a 
positive vira[ cutture and PER for RSV. IG associated 
with ribavirine and pavitizumab were administered 
before the treatment of the rejection by anti- 
thymogtobutines. He evotved favourabty without 
significant side effect of the anti-RSV treatment. 
Case 4: A 62-year-otd tung transptant patient was 
hospitatized for rhinorrhea, fever, myatgia, cough, 
severe wheezing and ground grass opacities in the 
middte robe. Withdrawa[ of mycophenotate was 
fottowed by a significant spirometric and ctinica[ 
improvement. Secondarity the BAL yietded a pos- 
itive PER resutt for RSV. He evotved favourabty 
without specific anti-RSV treatment. 
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Conclusions: The clinical outcome of RSV infec- 
tions in lung transplant patients seems to be de- 
pendent on the degree of immunosuppression. Re- 
duction of immunosuppression might be sufficient 
in selected cases and aggressive anti-RSV therapies 
could be restricted to patients under intense im- 
munosuppression. 
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Three Cases of Septic Gas Gangrene Post-Liver 
Transplantation Successfully Treated with 
Retransplantation 
S. Dob[ecki Lewis*, A.G. Tzakis, M.I. Morris. 
University o[ Miami~Jackson Memorial Hospital, 
Miami, FL, USA 
Background: Gas gangrene is a rare and devastat- 
ing infectious process that most often occurs fob 
[owing penetrating trauma or post-operatively. Gas 
gangrene of a transplanted liver has been reported 
rarely. We report three cases of gas gangrene fob 
[owing orthotopic liver transplantation. Blood cub 
tures were positive for Clostridium clostrdiil:orme 
in one case. In two other cases liver tissue from ex- 
planted specimens were positive for Enterobacter 
cloacae. Ultrasound demonstrated hepatic artery 
thrombosis and computed tomography imaging re- 
vea[ed diffuse necrosis with gas formation in each 
case. A[[ three patients were successfully treated 
with a combination of antibiotics and emergent re- 
transplantation. This is the largest series of post- 
transplant occurrences of septic gas gangrene. In 
the adult literature, a total of eight cases with 
two successful re-transplants have been previously 
reported. Hepatic artery thrombosis was a com- 
mon preceding event to these infections. Early 
diagnosis and aggressive combined medical and 
surgical treatment including re-transplantation are 
essential to successful treatment of these rare and 
usua[[y fata[ infections. 
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Characteristics of Invasive Candida (IC) 
Infections on Solid Organ Transplant (SOT) 
Recipients 
S.A. Grim*, S. Gupta, M. Ho[[oway, H. Sankary, 
J. Oberho[zer, E. Benedetti, N.M. Clark. University 
o[ Illinois at Chicago (UlC), Chicago, IL, USA 
Background & Objectives: The rate of IC due to 
non-a[bicans Candida (NAC) and associated azo[e- 
resistance has been rising. IC is a serious complica- 
tion of SOT and this study assesses the epidemio[- 
ogy of IC in our SOT population, fluconazo[e (FLU) 
resistance and outcomes. 
Methods: A retrospective review was performed 
of abdominal SOT recipients with IC between 
2001 and 2004. Cases were identified by cross- 
matchin g microbiology lab data of non-urinary, 
non-respiratory Candida isolates with our SOT 
database. Demographic, clinical and lab data were 
recorded; IRB approval was obtained. 
Results: 539 SOT were performed: 337 re- 
nal transplants (RT), 167 liver transplants (LT), 
17 kidney-pancreas transplants (KPT), 9 each 
small bowel (SBT) and pancreas transplants (PT). 
16 (3.0%) pts developed 17 episodes of IC within 
6 months (mo) of SOT (Table 1). The highest rates 
of IC were among LT and SBT. 9/17 episodes of 
IC (53%) were intraabdomina[ (IA), 5 (29%) were 
bloodstream (BS), 2 (12%)were both IA+BS, and 
1 (6%) was an abdominal wail abscess. 13/17 (77%) 
episodes completely responded (CR) to antifun- 
ga[ (AF) therapy and 4/17 (24%) were failures 
(4/4 patients expired). 
Tabte 1. IC within 6 mo of SOT. 
Organ 2001 2002 2003 2004 Overa[[ 
RT 0•65 3a170 0•94 I1108 4a1337 
(4.3%) (0.9%) (I .2%) 
LT 2•24 2a141 4151 4151 12a1167 
(8.3%) (4.9%) (7.8%) (7.8%) (7.2%) 
PT NA 014 012 013 019 
KPT 015 012 015 015 0117 
SBT NA 111 013 015 119 
(100%) (11.1%) 
Total 2/94 5/118 4/155 5/172 16/539 
(2.1%) (4.2%) (2.6%) (2.9%) (3.0%) 
Mean time 34 45 72.8 15.8 15.8 
to IC from (7-61) (5-125) (16-173) (3-33) (3-33) 
SOT (d) 
al combined LT/RT, counted twice. 
13 additional pts had late-onset (>6 mo post-SOT) 
IC during the study period: 6/13 (46%) RT, 3 (23%) 
combined LT/RT, 2 (15%) LT, and 1 each (8%) SBT 
and KPT. Sites included 10 (77%) BS and 3 (23%) 
IA and the mean time to IC after SOT was 45 mo 
(range 7-115). 10/13 (77%) had CR and 1 each (8%) 
had: repeat cultures negative without AF therapy, 
death prior to AF therapy, and death on therapy 
despite CR prior to death. For a[[ 30 episodes, NAC 
and FLU resistance rates varied by year (Table 2). 
NAC rates were as follows: 23% C. glabrata, 16% 
C. parapsilosis, 13% C. tropicalis, and 6% C. krusei. 
Tab[e 2. Incidence of NAC and FLU resistance. 
Year 2001 2002 2003 2004 
NAC 315 (60%) 719 (78%) 619 (67%) 217 (29%) 
FLU resistance 112 (50%) 219 (22%) 017 016 
Conclusions: Most early IC were in LT pts and most 
[ate IC were in RT pts. The incidence of IC was 
stable with a high rate of NAC. Fortunately, FLU 
resistance was rare. 
